⚕️Biotechnology is being completely reshaped by blockchain, turning research and discoveries that were once locked in labs into transparent, tradable assets that directly contribute to the scientific economy. @BioProtocol doesn’t just provide a platform it builds an entire ecosystem: #BioDAOs coordinate research, bioagents automate operational workflows, and IP-Tokens fractionalize scientific ownership, making breakthroughs liquid, shareable, and revenue-generating. This opens opportunities for scientists, investors, and patients to participate and share in the benefits of biomedical progress. A key strength is solving long-standing industry challenges: fragmented IP ownership, siloed data, and cumbersome licensing processes. By anchoring biomedical assets on-chain, BioProtocol ensures transparency in licensing, royalties, and collaboration while protecting sensitive data. $BIO plays a central role in governance, aligning incentives among researchers, investors, and the broader...
2.13K
4
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.